These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
895 related items for PubMed ID: 18439925
1. [A retrospective study of six patients with late-onset Pompe disease]. Saux A, Laforet P, Pagès AM, Figarella-Branger D, Pellissier JF, Pagès M, Labauge P. Rev Neurol (Paris); 2008 Apr; 164(4):336-42. PubMed ID: 18439925 [Abstract] [Full Text] [Related]
2. [Enzyme replacement therapy in Pompe's disease]. Merk T, Wibmer T, Schumann C, Krüger S. Med Klin (Munich); 2007 Jul 15; 102(7):570-3. PubMed ID: 17634875 [Abstract] [Full Text] [Related]
3. Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients. Hagemans ML, Winkel LP, Van Doorn PA, Hop WJ, Loonen MC, Reuser AJ, Van der Ploeg AT. Brain; 2005 Mar 15; 128(Pt 3):671-7. PubMed ID: 15659425 [Abstract] [Full Text] [Related]
7. Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up. Winkel LP, Van den Hout JM, Kamphoven JH, Disseldorp JA, Remmerswaal M, Arts WF, Loonen MC, Vulto AG, Van Doorn PA, De Jong G, Hop W, Smit GP, Shapira SK, Boer MA, van Diggelen OP, Reuser AJ, Van der Ploeg AT. Ann Neurol; 2004 Apr 30; 55(4):495-502. PubMed ID: 15048888 [Abstract] [Full Text] [Related]
8. Acid maltase deficiency in adults. A study of five cases. Lenders MB, Martin JJ, de Barsy T, Ceuterick C, Marchau M. Acta Neurol Belg; 1986 Apr 30; 86(3):152-60. PubMed ID: 3090848 [Abstract] [Full Text] [Related]
9. [Myopathy associated with respiratory insufficiency: diagnostic difficulties in adult-onset Pompe disease]. Merkli H, Pál E, Nagy F, Horváth R, Várdi VK, Komoly S, Illés Z. Orv Hetil; 2006 Jul 30; 147(30):1421-4. PubMed ID: 16977780 [Abstract] [Full Text] [Related]
10. [Glycogen storage disease (Pompe's disease) presenting as myopathy in the adult (author's transl)]. Stefan H, Böker DK, Müller J, Gullotta F. Dtsch Med Wochenschr; 1977 Oct 21; 102(42):1512-4. PubMed ID: 269788 [Abstract] [Full Text] [Related]
11. [Late infantile form of Pompe's disease. Deficiency of alpha-1,4-glucosidase (acid maltase)]. Colomer J, Roig M, Campistol J, Rullan G, Fernández-Alvarez E. An Esp Pediatr; 1984 Sep 15; 21(3):250-9. PubMed ID: 6391315 [Abstract] [Full Text] [Related]
12. A randomized study of alglucosidase alfa in late-onset Pompe's disease. van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ, Herson S, Kishnani PS, Laforet P, Lake SL, Lange DJ, Leshner RT, Mayhew JE, Morgan C, Nozaki K, Park DJ, Pestronk A, Rosenbloom B, Skrinar A, van Capelle CI, van der Beek NA, Wasserstein M, Zivkovic SA. N Engl J Med; 2010 Apr 15; 362(15):1396-406. PubMed ID: 20393176 [Abstract] [Full Text] [Related]
13. Adeno-associated virus-mediated transfer of human acid maltase gene results in a transient reduction of glycogen accumulation in muscle of Japanese quail with acid maltase deficiency. Lin CY, Ho CH, Hsieh YH, Kikuchi T. Gene Ther; 2002 May 15; 9(9):554-63. PubMed ID: 11973631 [Abstract] [Full Text] [Related]
14. Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype. Kroos MA, Pomponio RJ, Hagemans ML, Keulemans JL, Phipps M, DeRiso M, Palmer RE, Ausems MG, Van der Beek NA, Van Diggelen OP, Halley DJ, Van der Ploeg AT, Reuser AJ. Neurology; 2007 Jan 09; 68(2):110-5. PubMed ID: 17210890 [Abstract] [Full Text] [Related]
15. [Clinical manifestations, course and outcome of enzyme replacement therapy in Hungarian patients with Pompe's disease]. Bereznai B, Trauninger A, György I, Szakszon K, Almássy Z, Pál E, Herczegfalvi A, Várdi Visy K, Illés Z, Molnár MJ. Orv Hetil; 2011 Sep 25; 152(39):1569-75. PubMed ID: 21920843 [Abstract] [Full Text] [Related]
16. Diagnostic criteria for late-onset (childhood and adult) Pompe disease. American Association of Neuromuscular & Electrodiagnostic Medicine. Muscle Nerve; 2009 Jul 25; 40(1):149-60. PubMed ID: 19533647 [Abstract] [Full Text] [Related]
17. Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form. Verloes A, Massin M, Lombet J, Grattagliano B, Soyeur D, Rigo J, Koulischer L, Van Hoof F. Am J Med Genet; 1997 Oct 17; 72(2):135-42. PubMed ID: 9382133 [Abstract] [Full Text] [Related]
18. Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy. van der Beek NA, Hagemans ML, van der Ploeg AT, Reuser AJ, van Doorn PA. Acta Neurol Belg; 2006 Jun 17; 106(2):82-6. PubMed ID: 16898258 [Abstract] [Full Text] [Related]
19. Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients. Müller-Felber W, Horvath R, Gempel K, Podskarbi T, Shin Y, Pongratz D, Walter MC, Baethmann M, Schlotter-Weigel B, Lochmüller H, Schoser B. Neuromuscul Disord; 2007 Oct 17; 17(9-10):698-706. PubMed ID: 17643989 [Abstract] [Full Text] [Related]
20. [Three hypotonic neonates with hypertrophic cardiomyopathy: Pompe's disease]. Willemsen MA, Jira PE, Gabreëls FJ, van der Ploeg AT, Smeitink JA. Ned Tijdschr Geneeskd; 1998 Jun 13; 142(24):1388-92. PubMed ID: 9752027 [Abstract] [Full Text] [Related] Page: [Next] [New Search]